Reduction of Blood Recirculation in Veno-Venous ECMO

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCharite University, Berlin, Germany

About this trial

Blood which recirculates through the circuit of a veno-venous Extracorporeal Membrane Oxygenation (V-V ECMO) does not contribute to the systemic oxygenation of a patient on V-V ECMO and is called the recirculation fraction (Rf). Theoretically, the optimization of ECMO blood flow is possible using Rf measurements.

A prospective, observational study will be performed measuring the Rf of total ECMO blood flow in patients with acute respiratory distress syndrome (ARDS) on V-V ECMO with an ultrasound dilution technique.

ECMO blood flow will be optimized by reducing ECMO blood flow in accordance with the measured Rf as long as systemic oxygenation is not compromised.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Inclusion Criteria: * patients aged 18 years or older * ARDS * veno-venous ECMO Exclusion Criteria: * age \< 18 years * hemodynamic instability during measurement of recirculation * pregnancy * inability to obtain patient's consent or consent of legal guardian

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Successful ECMO blood flow reduction

Number of patients with a relevant recirculation fraction and successful ECMO blood flow reduction

Time frame
Once within the first week after initiation of ECMO therapy

Secondary outcomes

1

Recirculation fraction

Fraction of blood recirculating through the ECMO circuit

Time frame
Once within the first week after initiation of ECMO therapy
2

Arterial blood oxygen content

Arterial blood oxygen content before vs. after reduction of ECMO blood flow

Time frame
Once within the first week after initiation of ECMO therapy
3

Extracorporeal blood Flow

ECMO Blood Flow before vs. after reduction of ECMO blood flow

Time frame
Once within the first week after initiation of ECMO therapy
4

Extracorporeal gas flow

ECMO Sweep Gas flow

Time frame
Once within the first week after initiation of ECMO therapy

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.